Clinical Trial Update: Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy [Phase 2]

View source ↗

Summary

This Phase 2 trial update assesses how well transdermal brimonidine lowers intraocular pressure in patients with glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Brimonidine (brimonidine)

Snippet

Sponsor: Nanduri, Padma, M.D., FACS | Conditions: Glaucoma | Phase 2 | Status: UNKNOWN